Medicus Pharma Ltd., a biotech/life sciences company, focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops SkinJect, with an indication for basal cell carcinoma that is drug device combination product using novel dissolvable microneedle arrays for the treatment of non-melanoma skin cancers. The company was founded in 2015 and is headquartered in Toronto, Canada.

Sector

Healthcare

Industry

Biotechnology

CEO

Bokhari, Raza

Employees

Website

medicuspharma.com

IPO Date

2024-11-15

Headquarters

One First Canadian Place, Suite 3400, 100 King Street West, Toronto, Ontario, M5X 1A4, Canada

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Medicus Pharma MDCX

Medicus Pharma Earnings Call Summary

Medicus Pharma Earnings

Transcripts

Events

About Medicus Pharma Ltd.

Medicus Pharma
MDCX